Liquidia (LQDA) Cash from Investing Activities (2020 - 2026)

Liquidia (LQDA) recorded quarterly Cash from Investing Activities of -$2.8 million in Q1 2026, up 29.92% quarter-over-quarter from -$4.0 million in Q4 2025, and down 757.58% on a YoY basis from $430368.7 in Q1 2025.

Liquidia (LQDA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Liquidia's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 757.58% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$8.8 million (down 8.46% YoY), while the FY2025 annual figure was -$6.3 million, up 24.94% from the prior year.
  • Cash from Investing Activities was -$2.8 million for Q1 2026 at Liquidia, up from -$4.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q2 2022 to a low of -$10.5 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$1.8 million across 5 years, with a median of -$767500.0 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities soared 94.29% in 2022, then tumbled 12050.0% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$491000.0 in 2022, then surged by 58.04% to -$206000.0 in 2023, then tumbled by 2220.39% to -$4.8 million in 2024, then increased by 15.52% to -$4.0 million in 2025, then climbed by 29.92% to -$2.8 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$2.8 million (Q1 2026), -$4.0 million (Q4 2025), and -$911000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.83 Mn
Mar 31, 2026 -2.83 Mn
Dec 31, 2025 -4.04 Mn
Dec 31, 2025 -4.04 Mn
Sep 30, 2025 -911,000.00
Sep 30, 2025 -911,000.00
Jun 30, 2025 -1.06 Mn
Jun 30, 2025 -1.06 Mn
Mar 31, 2025 -330,000.00
Mar 31, 2025 -330,000.00
Dec 31, 2024 -4.78 Mn
Dec 31, 2024 -4.78 Mn
Sep 30, 2024 -1.75 Mn
Sep 30, 2024 -1.75 Mn
Jun 30, 2024 -1.29 Mn
Jun 30, 2024 -1.29 Mn
Mar 31, 2024 -624,000.00
Mar 31, 2024 -624,000.00
Dec 31, 2023 -206,000.00
Dec 31, 2023 -206,000.00